INTRODUCTION: ADAMTS-4, also referred to as aggrecanase-1, is a glutamyl endopeptidase capable of generating catabolic fragments of aggrecan analogous to those released from articular cartilage during degenerative joint diseases such as osteoarthritis. Efficient aggrecanase activity requires the presence of sulfated glycosaminoglycans (GAGs) attached to the aggrecan core protein, implying the contribution of substrate (GAG) recognition/binding site(s) to ADAMTS-4 activity. In the present study, we demonstrate that full length ADAMTS-4 (Mr ~68 kDa) undergoes autocatalytic C-terminal truncation to generate two discrete isoforms (Mr ~53 kDa and Mr ~40 kDa) which exhibit a marked reduction in affinity for binding to sulfated GAGs. The GAG-binding thrombospondin type I motif was retained following autocatalysis, demonstrating that sites present in the C-terminal "cysteine (cys)-rich" and/or "spacer" domains also effect binding of full length ADAMTS-4 to sulfated GAGs. Binding-competition experiments demonstrated interaction of the ADAMTS-4 cys-rich/spacer domains with aggrecan GAGs, and synthetic peptides mimicking putative ADAMTS-4 GAGbinding sequences competitively blocked binding of sulfated GAGs to full length ADAMTS-4, thereby identifying multiple GAG-binding sites which may contribute to ADAMTS-4 function.
METHODS:
) were expressed in CHO/A2 cells and purified from conditioned media. Autocatalytic digestions were performed by incubation at 37°C for various times, and ADAMTS-4 isoforms were visualized by silver staining or Western immunoblot analysis with a rabbit anti-human ADAMTS-4 antibody. Autocatalytic cleavage sites were determined by a combination of LC-TOF-Mass Spectrometry and N-and C-terminal sequencing.
GAG-binding affinity of ADAMTS-4 isoforms was assessed by affinity blotting using biotinylated heparin (bHep; Calbiochem) and by separation on a heparin-sepharose column. GAG binding-competition experiments were performed by preincubation of affinity blots with unlabelled heparin or native or deglycosylated aggrecan, or by preincubation of bHep with synthetic peptides containing putative GAGbinding sequences represented in the ADAMTS-4 cys-rich/spacer domains.
RESULTS:
Purified recombinant human ADAMTS-4 migrated on SDS-PAGE gels as a predominant Mr ~68 kDa band (Fig. 1A) . Following incubation at 37°C for various times up to 16 h, ADAMTS-4 was detected as isoforms of Mr ~68 kDa (p68), Mr ~53 kDa (p53) and Mr ~40 kDa (p40) (Fig. 1B) . Autocatalysis was confirmed by inactivity of the ADAMTS-4 ASM (Fig. 1C) . Affinity blotting demonstrated that while ADAMTS-4(p68) bound bHep in the presence of 0.5M NaCl, ADAMTS-4(p53) and ADAMTS-4(p40) did not (Fig. 2) . Likewise, the ADAMTS-4 C-terminal deletion mutant failed to bind bHep under these conditions. In support of these observations, while all ADAMTS-4 isoforms bound to heparin-sepharose, ADAMTS-4(p68) bound with signficantly higher affinity, eluting in the presence of 0.8M NaCl compared to 0.3M-0.4M for ADAMTS-4(p53) and ADAMTS-4(p40). The N-terminus of all ADAMTS-4 isoforms (p68, p53 and p40) was Phe 213 , as expected for furin-processed ADAMTS-4, indicating Cterminal truncation. Mass analyses and C-terminal sequencing revealed a C-terminus of Lys 694 for ADAMTS-4(p53), while ADAMTS-4(p40) had a C-terminus of Thr 581 . Both autocatalytic isoforms retained the GAGbinding TSP motif which is reported to be critical for aggrecan substrate recognition and cleavage (Fig. 3) .
In binding-competition experiments, preincubation of affinity blot membranes with unlabelled heparin blocked binding of bHep to ADAMTS-4(p68) in a dose-dependent manner. Similarly, preincubation of membranes in the presence of aggrecan also blocked binding of bHep to ADAMTS-4(p68), and this binding-competition was dependent on the presence of aggrecan GAGs. Preincubation of bHep in the presence of synthetic peptides containing putative GAG-binding sequences present in the ADAMTS-4 cys-rich/spacer domains (SKKKFDKC, FRKFRY or RRRPWAGRK) also blocked the binding of bHep to ADAMTS-4(p68). Neither a variant (control) peptide, nor poly-L-lysine, inhibited bHep binding, thus confirming the identification of multiple GAG-binding sites within the C-terminal region of ADAMTS-4.
DISCUSSION:
A defining feature of ADAMTS p roteases is the presence of one or more TSP type I motifs (or submotifs) which may bind to extracellular matrix GAGs. In the case of ADAMTS-4, the TSP motif is required for binding to aggrecan (via its GAG chains) and cleavage of this substrate (1). For ADAMTS-1, however, sites within the C-terminal "spacer" domain also bind sulfated GAGs (2), and we herein describe similar findings for ADAMTS-4. Autocatalytic C -terminal truncation of full length ADAMTS-4 [ADAMTS-4(p68)] generates two discrete isoforms, ADAMTS-4(p53) and ADAMTS-4(p40), which exhibit reduced affinity of binding to heparin (Figs. 1&2) . Since both of the truncated isoforms retained the TSP type I motif (Fig. 3) , it was evident that additional sites located within the ADAMTS-4 cysrich/spacer domains contribute to GAG binding and interaction with glycosylated aggrecan. Linear peptides mimicking the putative GAGbinding sequences competitively inhibited the binding of ADAMTS-4(p68) to bHep, while a control peptide or poly-L-lysine did not. However, secondary structure of ADAMTS-4(p68) was critical for optimal binding to sulfated GAGs, since treatment with reducing agents significantly diminished the affinity for bHep.
Recently, it was reported that C-terminal truncation may regulate (activate) ADAMTS-4 proteolytic activity (3), and in the present study we provide evidence that autocatalytic C -terminal truncation of ADAMTS-4 modulates (reduces) GAG-binding affinity. The loss of GAG-binding site(s) present in the cys-rich/spacer domains may result in "mobilization" of ADAMTS-4, facilitating access to proteolytically sensitive sites within the aggrecan core protein. Furthermore, since truncation of ADAMTS-4 appears to occur in vivo (3), modulation of GAG-binding properties by such processes is like ly to be influential in affecting ADAMTS-4 activity. 
